Merck
AI-Driven Retrosynthesis
The development of cost-effective and safe total synthetic routes for active pharmaceutical ingredients (APIs) is a painstaking and complex process. This critical early development stage significantly impacts overall manufacturing costs, dictates the required purification and isolation technologies along with inherent solvent usage, and consequently contributes to key environmental hotspots in pharmaceutical manufacturing.
Prof. Brahim Benyahia
Professor of Chemical Engineering, Loughborough University
Dr. Ewa Gajewska
Head of Product Management
Register for webinar
Prof. Brahim Benyahia, Dr. Ewa Gajewska
AI-Driven Retrosynthesis
Topics
Webinars on related topics
Products on related topics
White papers on related topics
More webinars from Merck
More webinars on similar topics
See the theme worlds for related content
Topic world Digitalization in the laboratory
The topic world Digitalization in the lab presents innovations and trends from digital data systems (ELN, LIMS) to laboratory robots and networked devices (IoT) to AI and machine learning.
Topic world Digitalization in the laboratory
The topic world Digitalization in the lab presents innovations and trends from digital data systems (ELN, LIMS) to laboratory robots and networked devices (IoT) to AI and machine learning.
